Shawn Iadonato, Ph.D.

Developing novel antibody therapies to combat the fentanyl and opioid epidemic.

Biotechnology entrepreneur and executive, Dr. Shawn Iadonato has a distinguished career as a founder and C-level executive (CEO, COO, CSO) for both public and private biotech companies. He has extensive experience in founding, financing, and building innovative businesses with groundbreaking technologies.